We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$9.81M
(+8%)
Cap. Flow
+$3.88M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.63M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.55M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.29M |
| 4 |
KKR & Co
KKR
|
+$941K |
| 5 |
Omega Healthcare
OHI
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$1.73M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$830K |
| 3 |
Johnson Controls International
JCI
|
+$821K |
| 4 |
SE
Spectra Energy Corp Wi
SE
|
+$571K |
| 5 |
Tapestry
TPR
|
+$462K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.21% |
| 2 | Real Estate | 16.84% |
| 3 | Healthcare | 12.91% |
| 4 | Technology | 12.84% |
| 5 | Financials | 10.25% |
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
- Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
- Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
- Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
- Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
- Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.
Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.